Veru Inc.

Company Listings from SPi: Veru Inc.

You are here: Home >> SPi Company Listings >> Veru Inc.

 

Veru Inc.

Website:
http://

Search for other references to "veru" on SPi News

Latest Veru Inc. News

Veru to Participate at Three Upcoming Healthcare Investor Conferences in New York MIAMI, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for prostate cancer treatment and...... 13:30 GMT Wednesday 28th August 2019

Veru to Ring NASDAQ Closing Bell on September 4th to Kick Off National Prostate Cancer Awareness Month MIAMI, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for prostate cancer treatment and...... 13:30 GMT Tuesday 27th August 2019

Veru Reports Higher Net Revenues and Gross Profit for its Fiscal 2019 Third Quarter MIAMI, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for prostate cancer treatment and...... 11:30 GMT Thursday 8th August 2019

Veru to Report Fiscal 2019 Third-Quarter Financial Results; Host Conference Call on August 8th MIAMI, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for prostate cancer treatment and...... 13:30 GMT Thursday 1st August 2019

Veru Announces Dismissal of Lawsuit; Prevails on All Counts in Motion for Summary Judgment MIAMI, July 18, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for prostate cancer treatment and...... 19:07 GMT Thursday 18th July 2019

Veru Announces Successful Completion of Pre-NDA Meeting with FDA for TADFIN (Tadalafil 5mg and Finasteride 5mg) Combination for the Treatment of Benign Prostatic Hyperplasia MIAMI, June 26, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for prostate cancer treatment and...... 13:30 GMT Wednesday 26th June 2019

Veru Adds Breakthrough Novel Androgen Deprivation Therapy Formulation to its Advancing Prostate Cancer Drug Pipeline Following Successful Meeting with FDA MIAMI, June 04, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for prostate cancer treatment and...... 13:00 GMT Tuesday 4th June 2019

Veru to Present at the Jefferies 2019 Global Healthcare Conference on June 4th MIAMI, May 28, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for prostate cancer treatment and p...... 13:30 GMT Tuesday 28th May 2019

Veru Reports Strong Fiscal 2019 Second-Quarter Financial Results        MIAMI, May 15, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU) an oncology and urology biopharmaceutical company developing novel medicines for prostate cancer treat...... 11:30 GMT Wednesday 15th May 2019

Veru to Report Fiscal 2019 Second-Quarter Financial Results; Host Conference Call on May 15th MIAMI, May 08, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for prostate cancer treatment and p...... 13:30 GMT Wednesday 8th May 2019

Buy Veru Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us